Newsstand | Page 14 | Aplastic Anemia and MDS International Foundation

Newsstand

Here's where you'll find a regularly updated, broad range of articles written by the AAMDSIF team, allied health organizations and news organizations. By staying well-informed, patients and families are practicing a form of self-support that will help them be more effective self-advocates when engaging with health care providers.

Q&A with PNH expert Dr. Bart Scott

Originally Published: 09/23/2016
Read our latest interview with Dr. Bart Scott as he discusses PNH.

Happy BMT Birthday, Robin Roberts!

Originally Published: 09/20/2016
"Good Morning America” co-anchor Robin Roberts is celebrating her fourth “birthday,” as she likes to say. It’s been four years since Roberts received a life-saving bone marrow transplant to treat myelodysplastic syndrome or MDS, a rare blood disorder. Throughout her difficult journey, Roberts remained resilient thanks to her beloved mother's refrain, "Everybody's got something." She held onto that phrase like a mantra. Now, Roberts, who started her career in the radio booth at WFPR in Hammond, Louisiana, is coming full circle to launch an intimate and compelling podcast called "Everybody's...

Foundation Update - September 2016

Originally Published: 09/16/2016
Foundation Update Newsletter - September 2016 New! MarrowStrong Awareness Campaign Kicks Off With DC Event Patients, families and healthcare professionals – lend us your ears!  We're introducing MarrowStrong, a multi-faceted, overarching awareness campaign designed to elevate our profile, expand public support for patient programs, fund research, improve treatments, and ultimately, find a cure for bone marrow failure diseases. This national campaign will officially launch on December 10 with a March for Marrow 5K Run & Walk in Washington, D.C. Find out about...

Heroic avatars for rare disease patients

Originally Published: 09/14/2016
Alexion Pharmaceuticals, Inc. (ALXN) today announced the launch of Uncommon Strength, a global campaign to raise awareness of rare diseases through the celebration of the extraordinary resilience and inner strength of those impacted by these diseases. Uncommon Strength (www.UncommonStrength.com) supports global rare disease communities, including those impacted by atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), hypophosphatasia (HPP), and lysosomal acid lipase deficiency (LAL-D) with educational information as well as interactive social media elements to...

PNH Update - September 2016

Originally Published: 09/08/2016

AAMDSIF in San Diego 9/17

Originally Published: 09/07/2016
Sept. 6, 2016        Contact: Barbara Holzer, holzer@aamds.org, (301) 279-7202, x106 After Misdiagnosis by Renowned Institution, Local Woman Gets New Lease on Life Thanks to Specialist at UC San Diego Health ROCKVILLE, MD – Seventy-four year old Anne Wells led a very active, independent life until two-and-a-half years ago, when she suddenly became so weak that she could no longer take care of herself. “It was a very scary time for me, but even more so for my children,” she said. Her daughter came from Colorado to look after her, but when she couldn’t wake her mother up one day and had to...

Celebrity attention boosts young patients

Originally Published: 08/28/2016
BOSSIER CITY, LA (KSLA) - LeBron James recently won his 3rd NBA Championship, but what he did for a young man in Bossier City is definitely considered a power move. Whether you like him or not, LeBron James has proven that he's one of - if not the best - players in the world right now. Some of LeBron's biggest fans might live in Bossier City. "LeBron James is the best player you can not tell me that he is not," said Kameron Washington. "First of all, when LeBron came back to Cleveland, they didn't even have Kevin Love or J.R. Smith," said Micah Johnson. Micah Johnson and his friend Kameron...

Aplastic Anemia Update - August 2016

Originally Published: 08/19/2016

Taming the nausea, vomiting caused by chemo

Originally Published: 08/11/2016
A drug currently used to treat several psychiatric conditions can help prevent nausea and vomiting in patients receiving chemotherapy, according to results from a large NCI-funded phase III clinical trial. Patients in the trial were being treated with chemotherapy agents that often cause substantial nausea and vomiting. Those who were randomly assigned to receive the drug olanzapine (Zyprexa®), given in combination with three standard antiemetic agents (drugs that help prevent nausea and vomiting), were far less likely to experience nausea, have vomiting episodes, or need “rescue” anti-...

Foundation Update - August 2016

Originally Published: 08/10/2016
Foundation Update Newsletter - August 2016   Advancing Clinical Trials Through Expanded Patient Input AAMDSIF is committed to improving the clinical trials process for the benefit of patients and researchers alike. Dr. Ellen Salkeld, our Director of Research, recently offered an update on the Foundation’s progress with the PACCT+ program since it was established a year ago. Learn more about PAACT+, and what the pharmaceutical industry is doing to spur recruitment for clinical trials.   Learn Online With AAMDSIF Webinars Register now...